Q: What is Intuniv used for?

Intuniv is used to treat attention deficit hyperactivity disorder .

Q: How does Intuniv work?

Mechanism of Action Intuniv belongs to a class of drugs known as alpha-2A adrenergic receptor agonists. While the exact mechanism for treating attention deficit hyperactivity disorder (ADHD) is not completely known, researchers believe it works by targeting the prefrontal cortex of the brain. The prefrontal cortex is the area responsible for executive functions, including: Maintaining focus and attention Controlling impulses Organizing tasks and managing time Intuniv is thought to mimic the effects of norepinephrine, a naturally occurring chemical in the brain. By binding to alpha-2A receptors on nerve cells, the medication helps strengthen the signals between these cells. This improved communication in the brain may help reduce symptoms of distractibility and impulsivity. Because Intuniv works differently than stimulant medications, it does not have the same effect on dopamine levels in the brain. It is often used alone or in combination with other ADHD treatments to help manage symptoms throughout the day.

Q: What are the active ingredients in Intuniv?

The active ingredient in Intuniv is guanfacine .

Q: What are the side effects of Intuniv?

Common side effects of Intuniv may include: somnolence fatigue hypotension and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Intuniv?

Intuniv belongs to the alpha-2 adrenergic receptor agonist drug class.

Q: Is Intuniv safe during pregnancy and breastfeeding?

Pregnancy There is limited information regarding the use of Intuniv in pregnant women. While animal studies have not demonstrated a clear risk of birth defects or other developmental issues, these results do not always predict human outcomes. Healthcare providers typically only prescribe this medication during pregnancy if the potential benefits outweigh the possible risks to the fetus. If you become pregnant or are planning to conceive while taking Intuniv, consult your doctor to discuss your treatment options. Breastfeeding It is currently unknown if guanfacine, the active ingredient in Intuniv, passes into human breast milk. Research in animals has shown that the drug can be present in milk, which suggests a possibility of exposure for nursing infants. Because of the potential for side effects in a breastfed child, it is important to discuss the risks and benefits of breastfeeding with a healthcare professional before using this medication.

Q: What forms and strengths does Intuniv come in?

Dosage Forms Intuniv is provided as an extended-release tablet. This formulation is designed to release the medication slowly into the body over time. To maintain the extended-release properties of the medication, the tablets must be swallowed whole. They should not be: Crushed Chewed Broken

Q: What is the FDA approval status of Intuniv?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Intuniv, which contains the active ingredient guanfacine in an extended-release formulation, for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). It is specifically indicated for use in pediatric patients aged 6 to 17 years. The medication may be prescribed as a standalone treatment (monotherapy) or as an add-on treatment (adjunctive therapy) to stimulant medications. Regulatory Classification Intuniv is not a controlled substance. Unlike many other ADHD treatments that are stimulants, it does not have a known potential for abuse or physical dependence. It belongs to a class of medications known as selective alpha-2A adrenergic receptor agonists. Safety and Monitoring There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required for this medication. However, the FDA-approved labeling includes important safety information regarding its potential to cause low blood pressure (hypotension), slow heart rate (bradycardia), and sedation. Regulatory guidelines recommend that healthcare providers monitor a patient's heart rate and blood pressure before starting treatment, after any dose increases, and periodically throughout the course of therapy.

Question 1

What is Intuniv?

Accepted Answer

Intuniv is an extended-release formulation of the medication guanfacine. It is classified as a central alpha-2A adrenergic receptor agonist and is a non-stimulant treatment. The medication works by targeting and activating specific receptors in the brain, particularly in the prefrontal cortex, to help balance neurological activity.

By interacting with these receptors, the medication helps to strengthen the brain's ability to process signals related to focus and impulse regulation. This mechanism of action allows it to influence behavioral control and cognitive function through a different pathway than stimulant-based therapies.

Question 2

What is Intuniv used for?

Accepted Answer

Intuniv is used to treat attention deficit hyperactivity disorder.

Question 3

How does Intuniv work?

Accepted Answer

Mechanism of Action

Intuniv belongs to a class of drugs known as alpha-2A adrenergic receptor agonists. While the exact mechanism for treating attention deficit hyperactivity disorder (ADHD) is not completely known, researchers believe it works by targeting the prefrontal cortex of the brain.

The prefrontal cortex is the area responsible for executive functions, including:

Maintaining focus and attention
Controlling impulses
Organizing tasks and managing time

Intuniv is thought to mimic the effects of norepinephrine, a naturally occurring chemical in the brain. By binding to alpha-2A receptors on nerve cells, the medication helps strengthen the signals between these cells. This improved communication in the brain may help reduce symptoms of distractibility and impulsivity.

Because Intuniv works differently than stimulant medications, it does not have the same effect on dopamine levels in the brain. It is often used alone or in combination with other ADHD treatments to help manage symptoms throughout the day.

Question 4

What are the active ingredients in Intuniv?

Accepted Answer

The active ingredient in Intuniv is guanfacine.

Question 5

What are the side effects of Intuniv?

Accepted Answer

Common side effects of Intuniv may include:

somnolence
fatigue
hypotension
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Intuniv?

Accepted Answer

Intuniv belongs to the alpha-2 adrenergic receptor agonist drug class.

Question 7

What is the dosage of Intuniv and how do I take it?

Accepted Answer

Intuniv should be taken exactly as prescribed by a healthcare provider. It is typically taken once a day, either in the morning or the evening, but it should be taken at the same time every day for consistent results.

When taking this medication, follow these instructions:

Swallow tablets whole: Do not crush, chew, or break the tablet. Breaking the tablet can release too much medicine into the body at once, which may increase the risk of side effects.
Food considerations: Intuniv can be taken with or without food. However, it should not be taken with a high-fat meal, as this can affect how the medication is absorbed.

If a dose is missed, it should be taken as soon as it is remembered. If it is almost time for the next scheduled dose, skip the missed dose and continue with the regular schedule. Do not take two doses at once to make up for a missed one.

If multiple consecutive doses are missed, contact a healthcare provider. They may need to provide a specific schedule to restart the medication safely.

Do not stop taking Intuniv suddenly without consulting a doctor. A healthcare professional will provide a plan to gradually decrease the dose. Stopping the medication abruptly can lead to a rapid increase in blood pressure and heart rate.

Question 8

Is Intuniv safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the use of Intuniv in pregnant women. While animal studies have not demonstrated a clear risk of birth defects or other developmental issues, these results do not always predict human outcomes. Healthcare providers typically only prescribe this medication during pregnancy if the potential benefits outweigh the possible risks to the fetus.

If you become pregnant or are planning to conceive while taking Intuniv, consult your doctor to discuss your treatment options.

Breastfeeding

It is currently unknown if guanfacine, the active ingredient in Intuniv, passes into human breast milk. Research in animals has shown that the drug can be present in milk, which suggests a possibility of exposure for nursing infants. Because of the potential for side effects in a breastfed child, it is important to discuss the risks and benefits of breastfeeding with a healthcare professional before using this medication.

Question 9

What forms and strengths does Intuniv come in?

Accepted Answer

Dosage Forms

Intuniv is provided as an extended-release tablet. This formulation is designed to release the medication slowly into the body over time.

To maintain the extended-release properties of the medication, the tablets must be swallowed whole. They should not be:

Crushed
Chewed
Broken

Question 10

What is the FDA approval status of Intuniv?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Intuniv, which contains the active ingredient guanfacine in an extended-release formulation, for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). It is specifically indicated for use in pediatric patients aged 6 to 17 years. The medication may be prescribed as a standalone treatment (monotherapy) or as an add-on treatment (adjunctive therapy) to stimulant medications.

Regulatory Classification

Intuniv is not a controlled substance. Unlike many other ADHD treatments that are stimulants, it does not have a known potential for abuse or physical dependence. It belongs to a class of medications known as selective alpha-2A adrenergic receptor agonists.

Safety and Monitoring

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required for this medication. However, the FDA-approved labeling includes important safety information regarding its potential to cause low blood pressure (hypotension), slow heart rate (bradycardia), and sedation. Regulatory guidelines recommend that healthcare providers monitor a patient's heart rate and blood pressure before starting treatment, after any dose increases, and periodically throughout the course of therapy.

Question 11

What should I know about Intuniv and withdrawal?

Accepted Answer

Risks of Stopping Suddenly

You should not stop taking Intuniv without first consulting your healthcare provider. Discontinuing the medication abruptly can lead to a sudden and dangerous increase in blood pressure and heart rate. This is often referred to as rebound hypertension.

Withdrawal Symptoms

If the medication is stopped too quickly, you may experience symptoms such as:

Headache
Confusion
Nervousness or agitation
Tremors or shaking
Rapid heart rate

Safe Discontinuation

To stop treatment safely, a doctor will typically recommend a gradual reduction in the dose. This tapering process usually involves decreasing the dose by no more than 1 mg every 3 to 7 days. Following a tapering schedule helps the body adjust and minimizes the risk of high blood pressure spikes. If you miss doses or stop taking the medication, your blood pressure should be monitored closely.

Intuniv

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Intuniv

Hospitals.net Disclosure